DUSSELDORF, Germany – (COMMERCIAL THREAD) – With their submission to the 42PLUS1 Pitch Award, many participants have already taken the first step to winning $ 1,500,000 in funding for the most innovative business ideas. The winners of the 42PLUS1 Pitch Award will be elected from a renowned jury of industry experts and investors at the DxPx Conference EU Grand Final on November 16.e in Düsseldorf, Germany. The DxPx Conference is an established industry and investor partnership conference for leaders in the diagnostics, digital health, precision medicine, and life science tools industry.
“We are thrilled with the large number of pitch submissions, which suggests that there are many innovative startups with a pipeline of disruptive ideas and technologies. Our mission is to support young companies as well as to promote innovative solutions in the fields of diagnostics, digital health, precision medicine and life science tools ”, says Lena Ehrenpreis, initiator of the DxPx conference and the 42PLUS1 Pitch Award.
8 satellite finalists presented live at the DxPx Conference US on July 27e and the jury chose a winner, obtaining a Wildcard for the final of the DxPx Conference EU: Alertgy, presented by CEO Marc Rippen. Alertgy has developed a 100% non-invasive, real-time, real-time, and long-lasting glucometer. As a leading biotech company, they strive to revolutionize the way people with diabetes and prediabetes manage their disease. SLS Partnering organizer invites Marc to the DxPx Conference EU, November 16e, to pitch with 7 other finalists for a funding of 1,500,000 USD. The other seven finalists remain to be found. Thus, entrepreneurs can submit their pitches online on www.42plus1.com from September 6e.
Pitches were not the only interesting item on the agenda of the first DxPx Conference US (July 27e – 31st), connecting industry leaders as well as renowned investors and startup founders with a local approach and a focus on the United States. Even as a fully digital format, due to the pandemic, the organizers managed to reach almost 500 feeds, 800 meetings, 200 participants from 13 countries with a high American concentration – 50% from the United States and Canada. With renowned knowledge partners such as Brown Gibbons Lang & Company, McDermott Will & Emery and Hologic and a versatile conference program followed by 4 days of digital partnership, it has become a key date for professionals. Panels at the conference touched on hot topics such as IPOs and PSPCs, precision medicine as the future of new cancer treatment, regulatory and reimbursement hurdles for digital diagnostic companies in the United States. , and the use of AI in medical diagnostics with notes from great speakers like Uplaksh Kumar (GRAIL), Alissa Lynch (Google) and Debbie Lin (Boehringer Ingelheim).
SLS Partnering is now looking forward to its flagship product – the DxPx EU conference, parallel to MEDICA on November 16e at the Maritim Hotel in Düsseldorf, Germany. To ensure maximum flexibility and results, participants will be able to use the digital partnership platform for 8 full days starting November 12.e – 20e.
With funding of $ 1,500,000, 42PLUS1 is the industry’s most sought-after Pitch Award in Europe and one of the largest in the world dedicated to the DxPx galaxy of diagnostic, digital health, precision medicine tools and life sciences. It underscores SLS Partnering’s commitment to supporting startups and growing businesses and can now make an even bigger difference for the DxPx startup galaxy. www.42plus1.com
DxPx was first hosted in 2019 as an international industry and investor partnership conference for leaders in diagnostics, digital health, precision medicine and life science tools. life to explore financing, licensing and mergers and acquisitions opportunities. The annual flagship conference takes place each November in Düsseldorf, Germany, and is accompanied by satellite conferences in the United States and China throughout the year.
About the SLS partnership:
SLS Partnering is an events and marketing agency that tailors its services to the specific needs of the life sciences industry. Built by scientists and marketers, SLS Partnering is your trusted partner in translating technology and scientific content into high-quality marketable stories that spark interest and emotion in customers and investors.